Viewing Study NCT07221851


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-02-01 @ 10:45 PM
Study NCT ID: NCT07221851
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-10
First Post: 2025-10-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Sponsor: Ascendis Pharma A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Turner Syndrome View
None Short Stature Homeobox Gene Mutation View
None Idiopathic Short Stature View
None Small for Gestational Age at Delivery View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Turner Syndrome View
None Noonan Syndrome View
None Growth Hormone View
None Short Stature View
None Growth Failure View
None Sex Chromosome Disorders View
None Chromosome Disorders View
None Endocrine System Diseases View
None Pituitary Hormones, Anterior View
None Pituitary Hormones View
None Hormones View
None Hormone Substitutes View
None Human Growth Hormone View
None Lonapegsomatropin View
None Sex Chromosome Disorders of Sex Development View
None Impaired Growth View
None somatropin View
None Growth Hormone Sufficiency View
None Short Stature Homeobox Gene Mutation View
None Short Stature Children Born Small for Gestational Age View
None Idiopathic Short Stature View